Although the implication of these mutations in the expression of EIF4A3 is not clear and should be further explored in future studies, these results provide valuable and clinically relevant information to understand the impact of dysregulated EIF4A3 in HCC samples and its implication in the development and progression of this cancer type. This evidence concerns the gene EIF4A3 and hepatocellular carcinoma.